Star Trader from Garda to Manage $1 Billion for Schonfeld Amid Ongoing Legal Disputes
In a significant development within the finance sector, Garda’s renowned star trader is set to take the helm of a substantial $1 billion fund under Schonfeld Strategic Advisors. This announcement comes amidst an ongoing lawsuit involving both parties, raising eyebrows and concerns within the investment community.
Continue readingGarda Investments Alleges Competitor Schonfeld of Unlawful Poaching of Key Portfolio Manager
In a significant development within the investment management sector, Garda Capital Partners, a Toronto-based investment firm, has publicly accused its competitor Schonfeld Strategic Advisors of unlawfully enticing away a star portfolio manager. This accusation raises questions about ethics and competitive practices in the finance industry as the firms jockey for top talent to manage investments effectively.
Continue readingMerck Adjusts Sales Forecast Amid Slowing Demand for Gardasil Vaccine in China
In a recent update, Merck & Co. has revised its sales outlook downward, largely attributed to subpar demand for its Gardasil vaccine in the Chinese market. The pharmaceutical giant is now bracing for a potential decline in sales as the uptake of their human papillomavirus (HPV) vaccine fails to meet projections.
Continue readingBC Partners to Divest Majority Stake in Canada’s GardaWorld in $5.2 Billion Deal
In a significant development within the private equity landscape, BC Partners has announced its agreement to sell a majority stake in GardaWorld Security Corporation, a prominent Canadian security company, for a substantial $5.2 billion. This major financial transaction marks a decisive move for BC Partners as it seeks to capitalize on the rapid growth of GardaWorld in the security services industry.
Continue reading